反应详情

The title compound was prepared using a procedure analogous to 4-(2,3-dimethylphenoxy)-1-(5-(4-(hydroxymethyl)phenyl)-3,4-dihydroquinolin-1(2H)-yl)butan-1-one except that 4-(hydroxymethyl)phenylboronic acid was replaced with 2-(methylthio)-4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyrimidine. LCMS, [M+H]+=528.4. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, J=5.3 Hz, 1H), 7.62 (s, 1H), 7.46 (s, 1H), 7.16-7.25 (m, 3H), 7.02 (t, J=7.8 Hz, 1H), 6.74 (d, J=7.5 Hz, 1H), 6.69 (d, J=5.1 Hz, 1H), 6.65 (d, J=8.4 Hz, 1H), 5.40 (s, 2H), 3.94 (t, J=5.5 Hz, 2H), 3.81 (t, J=6.8 Hz, 2H), 2.79 (t, J=7.2 Hz, 2H), 2.54-2.63 (m, 5H), 2.11-2.26 (m, 5H), 1.82-1.97 (m, 5H).